Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SARL PHARMACIE CENTRALE DE MONTREUIL : revenue, balance sheet and financial ratios

SARL PHARMACIE CENTRALE DE MONTREUIL is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTREUIL (93100), this company of category PME shows in 2024 a net income positive of 376 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL PHARMACIE CENTRALE DE MONTREUIL (SIREN 902777143)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 376 411 € 436 511 € 557 067 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, SARL PHARMACIE CENTRALE DE MONTREUIL generates positive net income of 376 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 557 k€ -> 376 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

376 411 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 151%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

150.591%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.091%

Solvency indicators evolution
SARL PHARMACIE CENTRALE DE MONTREUIL

Sector positioning

Debt ratio
150.59 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SARL PHARMACIE CENTRALE D... (150.59) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.09% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +10 pts over 3 years

In 2024, the financial autonomy of SARL PHARMACIE CENTRALE D... (37.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of SARL PHARMACIE CENTRALE DE MONTREUIL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SARL PHARMACIE CENTRALE DE MONTREUIL is estimated at 5 254 975 € (range 3 659 482€ - 7 861 744€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
3659k€ 5254k€ 7861k€
5 254 975 € Range: 3 659 482€ - 7 861 744€
NAF 5 année 2024

Valuation method used

Net Income Multiple
376 411 € × 14.0x = 5 254 976 €
Range: 3 659 482€ - 7 861 745€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SARL PHARMACIE CENTRALE DE MONTREUIL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SARL PHARMACIE CENTRALE DE MONTREUIL

What is the revenue of SARL PHARMACIE CENTRALE DE MONTREUIL ?

The revenue of SARL PHARMACIE CENTRALE DE MONTREUIL is not publicly disclosed (confidential accounts filed with INPI).

Is SARL PHARMACIE CENTRALE DE MONTREUIL profitable?

Yes, SARL PHARMACIE CENTRALE DE MONTREUIL generated a net profit of 376 k€ in 2024.

Where is the headquarters of SARL PHARMACIE CENTRALE DE MONTREUIL ?

The headquarters of SARL PHARMACIE CENTRALE DE MONTREUIL is located in MONTREUIL (93100), in the department Seine-Saint-Denis.

Where to find the tax return of SARL PHARMACIE CENTRALE DE MONTREUIL ?

The tax return of SARL PHARMACIE CENTRALE DE MONTREUIL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL PHARMACIE CENTRALE DE MONTREUIL operate?

SARL PHARMACIE CENTRALE DE MONTREUIL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.